99 related articles for article (PubMed ID: 8093155)
41. Impact of MHC class I gene on resistance to murine AIDS.
Makino M; Murphy DB; Melvold RW; Hartley JW; Morse HC
Scand J Immunol; 1995 Sep; 42(3):368-72. PubMed ID: 7660069
[TBL] [Abstract][Full Text] [Related]
42. Both naive and memory CD4 T cell subsets become anergic during MAIDS and each subset can sustain disease.
Koch S; Muralidhar G; Swain SL
J Immunol; 1994 Jun; 152(11):5548-56. PubMed ID: 7910621
[TBL] [Abstract][Full Text] [Related]
43. CD4+ subset regulation in viral infection. Preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice.
Gazzinelli RT; Makino M; Chattopadhyay SK; Snapper CM; Sher A; Hügin AW; Morse HC
J Immunol; 1992 Jan; 148(1):182-8. PubMed ID: 1345785
[TBL] [Abstract][Full Text] [Related]
44. In vivo immunologic deficits in mice with murine acquired immunodeficiency syndrome and the effect of LP-BM5 infection on rejection of skin from infected mice.
Rosenberg AS; Maniero TG; Morse HC
Transplant Proc; 1991 Feb; 23(1 Pt 1):167-9. PubMed ID: 1990505
[No Abstract] [Full Text] [Related]
45. Functional and phenotypic change of T cells in murine acquired immune deficiency.
Kanagawa O; Gayama S; Vaupel B
J Immunol; 1994 May; 152(9):4671-9. PubMed ID: 8157980
[TBL] [Abstract][Full Text] [Related]
46. Analysis of role of CD8+ T cells in resistance to murine AIDS in A/J mice.
Makino M; Chattopadhyay SK; Hartley JW; Morse HC
J Immunol; 1992 Sep; 149(5):1702-6. PubMed ID: 1506689
[TBL] [Abstract][Full Text] [Related]
47. In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS).
Gazzinelli RT; Giese NA; Morse HC
J Exp Med; 1994 Dec; 180(6):2199-208. PubMed ID: 7964495
[TBL] [Abstract][Full Text] [Related]
48. The inflammatory macrophage response to MCMV in mice with a retroviral immunodeficiency syndrome (MAIDS).
Allcock RJ; Peacock CD; Price P
J Leukoc Biol; 1996 Jul; 60(1):44-50. PubMed ID: 8699122
[TBL] [Abstract][Full Text] [Related]
49. Modulation of specific T cell responses by concurrent infection with Leishmania major and LP-BM5 murine leukemia viruses.
Doherty TM; Morse HC; Coffman RL
Int Immunol; 1995 Jan; 7(1):131-8. PubMed ID: 7718509
[TBL] [Abstract][Full Text] [Related]
50. Murine AIDS protects mice against experimental cerebral malaria: down-regulation by interleukin 10 of a T-helper type 1 CD4+ cell-mediated pathology.
Eckwalanga M; Marussig M; Tavares MD; Bouanga JC; Hulier E; Pavlovitch JH; Minoprio P; Portnoï D; Rénia L; Mazier D
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8097-101. PubMed ID: 8058763
[TBL] [Abstract][Full Text] [Related]
51. Correlation between levels of immunoglobulins and immune complexes in plasma of C57BL/6 and C57L/J mice infected with MAIDS retrovirus.
Even C; Hu B; Erickson L; Plagemann PG
Viral Immunol; 1992; 5(1):39-50. PubMed ID: 1319170
[TBL] [Abstract][Full Text] [Related]
52. Analysis of antigen receptor signaling in B cells from mice with a retrovirus-induced acquired immunodeficiency syndrome.
Selvey LA; Morse HC; June CH; Hodes RJ
J Immunol; 1995 Jan; 154(1):171-9. PubMed ID: 7995937
[TBL] [Abstract][Full Text] [Related]
53. Overexpression of interleukin-15 prevents the development of murine retrovirus-induced acquired immunodeficiency syndrome.
Umemura M; Nishimura H; Yajima T; Wajjwalk W; Matsuguchi T; Takahashi M; Nishiyama Y; Makino M; Nagai Y; Yoshikai Y
FASEB J; 2002 Nov; 16(13):1755-63. PubMed ID: 12409318
[TBL] [Abstract][Full Text] [Related]
54. Timed ablation of regulatory CD4+ T cells can prevent murine AIDS progression.
Beilharz MW; Sammels LM; Paun A; Shaw K; van Eeden P; Watson MW; Ashdown ML
J Immunol; 2004 Apr; 172(8):4917-25. PubMed ID: 15067071
[TBL] [Abstract][Full Text] [Related]
55. Interactions between murine AIDS (MAIDS) and toxoplasmosis in co-infected mice.
Lacroix C; Levacher-Clergeot M; Chau F; Sumuyen MH; Sinet M; Pocidalo JJ; Derouin F
Clin Exp Immunol; 1994 Nov; 98(2):190-5. PubMed ID: 7955521
[TBL] [Abstract][Full Text] [Related]
56. The role of IL-12 in the control of MCMV is fundamentally different in mice with a retroviral immunodeficiency syndrome (MAIDS).
Peacock CD; Price P
Immunol Cell Biol; 1999 Apr; 77(2):131-8. PubMed ID: 10234548
[TBL] [Abstract][Full Text] [Related]
57. Chemical sympathectomy has no effect on the severity of murine AIDS: murine AIDS alone depletes norepinephrine levels in infected spleen.
Kelley SP; Moynihan JA; Stevens SY; Grota LJ; Felten DL
Brain Behav Immun; 2002 Apr; 16(2):118-39. PubMed ID: 11908922
[TBL] [Abstract][Full Text] [Related]
58. Unique CD4(+) T cells in TCR alpha chain-deficient class I MHC-restricted TCR transgenic mice: role in a superantigen-mediated disease process.
Hayashi RJ; Kanagawa O
Int Immunol; 1999 Sep; 11(9):1581-90. PubMed ID: 10464179
[TBL] [Abstract][Full Text] [Related]
59. Aggravation of both Trypanosoma cruzi and murine leukemia virus by concomitant infections.
Silva JS; Barral-Netto M; Reed SG
Am J Trop Med Hyg; 1993 Nov; 49(5):589-97. PubMed ID: 8250098
[TBL] [Abstract][Full Text] [Related]
60. CTL responses to the gag polyprotein encoded by the murine AIDS defective retrovirus are strain dependent.
Schwarz DA; Green WR
J Immunol; 1994 Jul; 153(1):436-41. PubMed ID: 8207252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
